1.

Kim JW, Evans C, Weidemann A, Takeda N, Lee YS, Stockmann C, Branco-Price C, Brandberg F, Leone G, Ostrowski MC, Johnson RS. 
"Loss of fibroblast HIF-1α accelerates tumorigenesis."
Cancer Res. 2012 May 3. [Epub ahead of print].

2.

Meinecke AK, Nagy N, D'Amico Lago G, Kirmse S, Klose R, Schrödter K, Zimmermann A, Helfrich I, Rundqvist H, Theegarten D, Anhenn O, Orian-Rousseau V, Johnson RS, Alitalo K, Fischer JW, Fandrey J, Stockmann C.
"Aberrant mural cell recruitment to lymphatic vessels and impaired lymphatic drainage in a murine model of pulmonary fibrosis."
Blood. 2012 Apr 30. [Epub ahead of print].

3.

Stockmann C, Kirmse S, Helfrich I, Weidemann A, Takeda N, Doedens A, Johnson RS.
"A wound size-dependent effect of myeloid cell-derived vascular endothelial growth factor on wound healing."
J Invest Dermatol. 2011 Mar;131(3):797-801. Epub 2010 Nov 25. 

4.

Kerdiles YM, Stone EL, Beisner DL, McGargill MA, Ch'en IL, Stockmann C, Katayama CD, Hedrick SM.
"Foxo transcription factors control regulatory T cell development and function."
Immunity. 2010 Dec 14;33(6):890-904. 

5.

Doedens AL, Stockmann C, Rubinstein MP, Liao D, Zhang N, DeNardo DG, Coussens LM, Karin M, Goldrath AW, Johnson RS.
"Macrophage expression of hypoxia-inducible factor-1 alpha suppresses T-cell function and promotes tumor progression."
Cancer Res. 2010 Oct 1;70(19):7465-75. Epub 2010 Sep 14. 

6.

Stockmann C, Kerdiles Y, Nomaksteinsky M, Weidemann A, Takeda N, Doedens A, Torres-Collado AX, Iruela-Arispe L, Nizet V, Johnson RS.
"Loss of myeloid cell-derived vascular endothelial growth factor accelerates fibrosis."
Proc Natl Acad Sci U S A. 2010 Mar 2;107(9):4329-34. Epub 2010 Feb 8. 

7.

Takeda N, O'Dea EL, Doedens A, Kim JW, Weidemann A, Stockmann C, Asagiri M, Simon MC, Hoffmann A, Johnson RS.
"Differential activation and antagonistic function of HIF-{alpha} isoforms in macrophages are essential for NO homeostasis."
Genes Dev. 2010 Mar 1;24(5):491-501. 

8.

Weidemann A, Kerdiles YM, Knaup KX, Rafie CA, Boutin AT, Stockmann C, Takeda N, Scadeng M, Shih AY, Haase VH, Simon MC, Kleinfeld D, Johnson RS.
"Glial cell response is an essential component of hypoxia-induced erythropoiesis in mice."
J Clin Invest. 2009 Nov;119(11):3373-83. Epub 2009 Oct 5. 

9.

Frede S, Stockmann C, Winning S, Freitag P, Fandrey J. 
"Hypoxia-inducible factor (HIF) 1alpha accumulation and HIF target gene expression are impaired after induction of endotoxin tolerance." 2009 May 15. J Immunol. 182(10):6470-6. 

10.

Stockmann C, Doedens A, Weidemann A, Zhang N, Takeda N, Greenberg JI, Cheresh DA, Johnson RS.
"Deletion of vascular endothelial growth factor in myeloid cells accelerates tumorigenesis." 2008 Dec 11. Nature. 456(7223):814-8. 

11.

Greenberg JI, Shields DJ, Barillas SG, Acevedo LM, Murphy E, Huang J, Scheppke L, Stockmann C, Johnson RS, Angle N, Cheresh DA.
"A role for VEGF as a negative regulator of pericyte function and vessel maturation." 2008 Dec 11. Nature. 456(7223):809-13. 

12.

Stockmann C, Fandrey J.
"Hypoxia-induced erythropoietin production: a paradigm for oxygen-regulated gene expression." 2006 Oct. Clin Exp Pharmacol Physiol. 33(10):968-79. 

13.

Frede S, Stockmann C, Freitag P, Fandrey J.
"Bacterial lipopolysaccharide induces HIF-1 activation in human monocytes via p44/42 MAPK and NF-kappaB." 2006 Jun 15. Biochem J. 396(3):517-27. 

14.

Nakano Y, Imagawa S, Matsumoto K, Stockmann C, Obara N, Suzuki N, Doi T, Kodama T, Takahashi S, Nagasawa T, Yamamoto M.
"Oral administration of K-11706 inhibits GATA binding activity, enhances hypoxia-inducible factor 1 binding activity, and restores indicators in an in vivo mouse model of anemia of chronic disease." 2004 Dec 15. Blood. 104(13):4300-7.